Streetbeat News

Analyst Ratings

FL

Over the past 3 months, 20 analysts have published their opinion on Foot Locker (NYSE:FL) stock. The company has an average price target of $22.6, a decrease of 30.76% from the previous average price target of $32.64. The ratings are mixed with 2 bullish, 4 somewhat bullish, 11 indifferent, 1 somewhat bearish, and 2 bearish.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 1:00 pm

FMX

Fomento Economico (NYSE:FMX) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average price target is $129.0, indicating an upside from the current price of $120.96. This average has increased by 9.95% from the previous average price target of $117.33.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 1:00 pm

KW

B of A Securities has downgraded Kennedy-Wilson Holdings (NYSE:KW) from Neutral to Underperform and lowered the price target from $18 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:59 pm

VRNOF

Zuanic & Associates analyst Pablo Zuanic has initiated coverage on Verano Holdings (OTC:VRNOF) with an Overweight rating.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:59 pm

SONO

B of A Securities analyst John Babcock has downgraded Sonos (NASDAQ:SONO) from Buy to Neutral and lowered the price target from $20 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:56 pm

MRMD

Zuanic & Associates has initiated coverage on MariMed (OTC:MRMD) with an Overweight rating.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:53 pm

UDR

Wells Fargo analyst James Feldman has downgraded UDR (NYSE:UDR) from Overweight to Equal-Weight and lowered the price target from $42.5 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:52 pm

APPN

AYX

IAC

RMAX

Top Wall Street analysts have updated their outlooks on several stocks. Alteryx's price target was increased by Piper Sandler from $30 to $32, while IAC's price target was cut by Keybanc from $81 to $72. DA Davidson raised Appian's price target from $50 to $55, and Morgan Stanley cut RE/MAX's price target from $19.5 to $9. Other companies mentioned include Mirati Therapeutics, Alphatec Holdings, Alto Ingredients, EverQuote, Ventas, and Compass.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 12:50 pm

ES

Evercore ISI Group analyst Durgesh Chopra has downgraded Eversource Energy (NYSE:ES) from Outperform to In-Line and lowered the price target from $84 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:50 pm

FMX

Itau BBA analyst Alejandro Fuchs has downgraded Fomento Economico (NYSE:FMX) from Outperform to Market Perform and set a price target of $127.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:47 pm